These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Mitochondria-Targeted Delivery of Camptothecin Based on HPMA Copolymer for Metastasis Suppression. Yi X; Yan Y; Shen X; Li L; Huang Y Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893790 [TBL] [Abstract][Full Text] [Related]
83. Autophagy responsive intra-intercellular delivery nanoparticles for effective deep solid tumor penetration. Wang F; Xie D; Lai W; Zhou M; Wang J; Xu R; Huang J; Zhang R; Li G J Nanobiotechnology; 2022 Jun; 20(1):300. PubMed ID: 35752856 [TBL] [Abstract][Full Text] [Related]
84. Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting. Fu X; Shi Y; Qi T; Qiu S; Huang Y; Zhao X; Sun Q; Lin G Signal Transduct Target Ther; 2020 Nov; 5(1):262. PubMed ID: 33154350 [TBL] [Abstract][Full Text] [Related]
85. Cascade-Targeting of Charge-Reversal and Disulfide Bonds Shielding for Efficient DOX Delivery of Multistage Sensitive MSNs-COS-SS-CMC. Cui L; Liu W; Liu H; Qin Q; Wu S; He S; Zhang Z; Pang X; Zhu C Int J Nanomedicine; 2020; 15():6153-6165. PubMed ID: 32884269 [TBL] [Abstract][Full Text] [Related]
86. Overcoming chemotherapy resistance Zhou M; Li L; Li L; Lin X; Wang F; Li Q; Huang Y Acta Pharm Sin B; 2019 May; 9(3):615-625. PubMed ID: 31193791 [TBL] [Abstract][Full Text] [Related]
87. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man. Lu ZR Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431 [TBL] [Abstract][Full Text] [Related]
88. Copolymers of 2-methacryloyloxyethyl phosphorylcholine (MPC) as biomaterials. Nakabayashi N; Iwasaki Y Biomed Mater Eng; 2004; 14(4):345-54. PubMed ID: 15472384 [TBL] [Abstract][Full Text] [Related]
89. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting. Li L; Yang Q; Zhou Z; Zhong J; Huang Y Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960 [TBL] [Abstract][Full Text] [Related]
90. Improved mitochondrial targeting effect of HPMA copolymer by SS20 peptide mediation and nonendocytosis pathway. Liu Y; Li Q; Xiong X; Zhou Z J Pept Sci; 2019 Feb; 25(2):e3144. PubMed ID: 30588703 [TBL] [Abstract][Full Text] [Related]
91. Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy. Xiang Y; Chen L; Zhou R; Huang Y Int J Pharm; 2019 Oct; 570():118668. PubMed ID: 31494237 [TBL] [Abstract][Full Text] [Related]
92. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies. Li L; Zhou M; Huang Y Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570 [TBL] [Abstract][Full Text] [Related]
93. Mitochondria-targeting and cell-penetrating peptides-co-modified HPMA copolymers for enhancing therapeutic efficacy of α-tocopheryl succinate. Liu Y; Li Q; Xiong X; Huang Y; Zhou Z J Mater Chem B; 2018 Dec; 6(46):7674-7683. PubMed ID: 32254889 [TBL] [Abstract][Full Text] [Related]
94. Charge-Reversible Multifunctional HPMA Copolymers for Mitochondrial Targeting. Wang F; Sun W; Li L; Li L; Liu Y; Zhang ZR; Huang Y ACS Appl Mater Interfaces; 2017 Aug; 9(33):27563-27574. PubMed ID: 28762267 [TBL] [Abstract][Full Text] [Related]